The CHOICE (Choice of health options in prevention of cardiovascular events) replication trial.
- Conditions
- Acute coronary syndromeCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12608000182392
- Lead Sponsor
- ANZAC Research Institute, Concord Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 500
Diagnosis of ACS in the four weeks prior to recruitment; refusal of the initial invitation to participate in standard CR; failure to attend initial CR assessment.
Clinical diagnosis of uncompensated, severe cardiac failure (Class IV); uncontrolled arrhythmia or angina; severe or symptomatic aortic stenosis; persistent hypotension (SBP < 90mmHg); clinical diagnosis of a severe coexisting medical condition that would prevent participation (eg, dementia, a terminal illness, severe rheumatoid arthritis); or insufficient English to provide written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method